Purpose The pattern and frequency of secondary chromosome abnormalities in t(14;18)-carrying nonHodgkin lymphomas (NHL) were evaluated for diVerences in relation to histologic NHL subtype and patients' outcome. Methods One hundred and forty-nine NHL patients with t(14;18) and complete cytogenetic, morphologic, and clinical information were selected. Results One hundred and twelve cases were follicular lymphoma (FL) and 37 were diVuse large B-cell lymphoma (DLBCL). One hundred and forty cases showed secondary aberrations (94%, median = 6.0). The most frequent were losses from chromosome arms 1p and 6q and +7 (26%). Loss from 1q, +7, and +12 were more frequent in DLBCL than in FL. Loss from 1p, Xp, and ¡16 were more frequent in FL grade 3 than in FL grades 1 and 2. Patients with <6.0 secondary cytogenetic aberrations had better prognosis than did those with a higher number of aberrations. Trisomy 21 was associated with shorter patient survival. FLIPI score, the number of secondary chromosomal aberrations, and +21 were all of independent prognostic value in Cox multivariate analysis. FL grade 1-3a patients that had received chemotherapy, showed a higher frequency of i(6p) and loss from 6q. Conclusion Secondary chromosomal aberrations showed some correlation with the morphologic subgroups of t(14;18)-NHL. Trisomy 21 and the presence of >6.0 secondary cytogenetic aberrations both correlated with shorter overall survival.
Introduction
Non-Hodgkin lymphomas (NHL) are a pathogenetically heterogeneous group of neoplastic diseases characterized cytogenetically by several speciWc chromosome abnormalities. A 14;18-translocation is the most frequent primary chromosomal aberration in NHL (Johansson et al. 1995) . The translocation juxtaposes the BCL2 protooncogene in 18q21 and the immunoglobulin heavy-chain gene (IGH) in 14q32 (Yunis et al. 1982; Tsujimoto et al. 1984 Tsujimoto et al. , 1985 Bakhshi et al. 1985) . t(14;18) is most commonly (80-90%) seen in follicular lymphomas (FL), but occurs also in 13-17% of diVuse large B-cell lymphoma (DLBCL) (Barrans et al. 2003; Iqbal et al. 2004 ). The t(14;18) is rarely found as the sole chromosomal abnormality, indicating that secondarily acquired aberrations often contribute to the pathogenetic process. Histologic transformation of FL to the more aggressive DLBCL occurs in 10-60% of the cases (Lossos and Levy 2003) . This transformation, which is the most important event in the course of FL in terms of outcome and death rate (Bastion et al. 1997) , is often associated with the occurrence of secondary chromosome aberrations in the lymphoma karyotype (Johansson et al. 1995; Horsman et al. 2001) .
In the present study, we evaluated the frequency and pattern of secondary chromosome abnormalities in t(14;18)-carrying NHL in relation to morphologic disease subgroups and clinical outcome.
Materials and methods
Selected for examination were 149 NHL cases with the speciWc translocation t(14;18)(q32;q21) as the primary chromosomal aberration, and for which complete cytogenetic (Appendices 1 and 2) and clinical data were available. All cases were retrieved from the archives of the Departments of Medical Genetics, Pathology, and Medical Oncology, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo, Norway. The cases were Gbanded and karyotyped as part of our cytogenetic diagnostic service during the years 1996-2002. The specimens were mostly lymph node biopsies from primary nodal disease (n = 139), but also bone marrow aspirates (n = 7) and biopsies from non-nodal tumors (n = 3). In seven cases, cytogenetic analyses were performed on bone marrow aspirates whereas the histologic evaluation was done on corresponding lymph node biopsies. Forty-three of the karyotypes were previously published (Teixeira et al. 2000; Aamot et al. 2002; Torlakovic et al. 2006 ). This study was approved by the Institutional Review Board.
Cytogenetic analysis

G-banding and karyotyping
Cytogenetic analysis was performed by standard methods using short-term cultures for 24 h at 37°C. The harvested, dividing cells were G-banded with trypsin and Leishman staining. Metaphase cells were captured and analyzed on a CytoVysion system (Applied Imaging, Santa Clara, CA, USA). Whenever possible, 15 metaphase cells were karyotyped in accordance with ISCN guidelines (2005) . In case 99-643 (Appendix 2), two biopsies of the same tumor were cultured and the karyotypes were combined.
M-FISH analysis
Ninety-nine cases showed chromosome rearrangements that were not possible to describe completely using G-banding alone. Of these 99, 30 showed a fair number of metaphases of acceptable quality and therefore were suitable for M-FISH analysis. The revised Gbanding + M-FISH karyotype was used in cases where both were available. M-FISH analyses were performed on freshly dropped metaphase preparations when material was available, otherwise on previously Gbanded chromosome preparations which were dismounted, destained, and pretreated as described by Teixeira et al. (2000) , followed by an application of the M-FISH protocol described by Aamot et al.(2002) .
The number of secondary abnormalities was counted as the number of diVerent breakpoints as well as the number of gains/losses of entire chromosomes. Duplications and interstitial deletions were counted as one aberration, whereas inversions and isochromosomes were counted as two. Two diVerent aberrations on the same chromosome were counted as two. When there was more than one copy of any given aberration, the aberration was counted only once, except if the extra copy resulted in gain/loss of chromosome material. In cases with marker chromosomes, each marker was counted as one secondary abnormality.
Patients and treatment
Eighty-seven (58%) men and 62 (42%) women with a median age of 53 years (range 21-81 years) were included in the analysis. Clinical data were retrieved from a data base with clinical information on all lymphoma patients recorded prospectively including histology, results of staging procedures, and blood tests at primary diagnosis as well as treatment, remission status, and status at follow-up examinations. Staging procedures included, in addition to histological examination, CT scans of the chest, abdomen, and pelvic region and bone marrow biopsy. Overall survival was recorded for all patients deWned as time from diagnostic biopsy till death or the last time patients were recorded alive. For patients with biopsy with cytogenetic examination taken at relapse or progression, survival analysis was also performed from the time of the relevant biopsy. Survival data were collected until August 2005. The age and sex distribution was similar for the diVerent histologic subgroups. Median observation time from primary diagnosis was 62 months. The patients were treated as follows: FL patients with disseminated disease without symptoms were followed regularly without treatment while those with localized disease received Weld radiotherapy. Patients requiring therapy received chlorambucil monotherapy or a more aggressive regimen (CHOP; cyclophosphamide, doxorubicin, vincristine, and prednisone) if a more rapid tumor response was needed. During the latter half of the study period, the chimeric anti-CD20 antibody rituximab was used as monotherapy from diagnosis in a few cases and in combination with chemotherapy at relapse. Patients with DLBCL and FL grade 3 were given doxorubicin-based chemotherapy. Relapsing DLBCL patients were given salvage combination chemotherapy and, if responsive, consolidation with high dose therapy with autologous stem cell support. Ninety of the 149 patients had not received chemotherapy before the biopsy was taken. Eighty-one of the biopsies were taken at relapse or progression. Median time from the primary diagnosis for these 81 cases was 41 months. As FL grades 1-3a are generally considered indolent lymphomas, they may go undetected for some time in many patients. Therefore, the biopsy taken at time of diagnosis may not coincide with the time the lymphoma originated. Additional clinical information is summarized in Table 1 .
Histology
All cases were morphologically reviewed for conWrmation of the diagnosis as part of this study by a single pathologist (E.T.) using WHO criteria (Mann and Berard 1983; JaVe et al. 2001 ). There were 112 FL and 37 DLBCL. The distribution among the subgroups of FL was as follows: FL grade 1: 31, FL grade 2: 60, FL grade 3a: 15, and FL grade 3b: 5. In one case, histologic grade could not be determined; however, FL grade 3b and DLBCL were excluded. In clinical terms, FL grade 3b may be considered as DLBCL-like lymphoma . Seventy-four lymphomas were FL without subsequent transformation, 17 were DLBCL transformed from FL, 25 patients had primary DLBCL and in 33 patients, a histologic transformation was diagnosed in a subsequent biopsy after a median observation time of 38 months (Table 1) . Median time from the diagnosis to the cytogenetic analysis was 47 months for FL grade 1-3a and 27 months for FL grade 3b and DLBCL (Table 1) .
Statistical analysis
We used Fisher's Exact Test when analyzing diVerences among the diVerent chromosomes involved in secondary abnormalities in the morphologic subgroups of NHL and the Mann-Whitney non-parametric test when testing the frequencies of secondary abnormalities. All P-values were two-sided and considered statistically signiWcant when P < 0.05. Statistical 
Results
Frequency and pattern of secondary chromosome abnormalities
Complete karyotypes are given in Appendices 1 and 2. M-FISH analysis was, because of suboptimal hybridization conditions, successful in only 15 of the 30 cases in which it was attempted. One hundred and forty cases (94%) had aberrations additional to the t(14;18). The median in all 149 cases was 6.0 (mean 6.5) secondary anomalies per case (range 0-23 aberrations). The majority of the 149 NHL cases (77%) was hyperdiploid and had only one abnormal clone (80%). The most frequent secondary aberrations in our series are listed in Table 2 .
FL versus DLBCL
Only 7% (n = 8) of the FL and 3% (n = 1) of the DLBCL had the t(14;18) as the sole anomaly; this diVerence was not statistically signiWcant. Both the 112 FL and the 37 DLBCL were mainly hyperdiploid (75 vs. 81%) and had one abnormal clone (78 vs. 87%).
The FL showed a median of 5.5 (mean 6.3) secondary anomalies per case with a range from 0 to 22, whereas the DLBCL showed a median of 6.0 (mean 6.9) aberrations per case with a range from 0 to 23. This diVerence was not statistically signiWcant (P = 0.398, Mann-Whitney U test). A trend was seen when comparing FL grades 1-3a with a median number of 5.0 secondary aberrations with FL grade 3b and DLBCL which showed a median number of 7.0 secondary aberrations (P = 0.092, Mann-Whitney U test).
Only those secondary aberrations with frequencies >10% were evaluated in relation to NHL histologic subtype (Table 3) . Three aberrations, namely loss from 1q, trisomy 7, and trisomy 12, were signiWcantly more frequent in DLBCL than in FL. Loss from 1q was seen in 5% of FL versus 22% in DLBCL (P = 0.004, Fisher's Exact Test), trisomy 7 in 20% in FL versus 46% in DLBCL (P = 0.003, Fisher's Exact Test), and, Wnally, trisomy 12 in 10% in FL versus 24% in DLBCL (P = 0.047, Fisher's Exact Test). Similar results were seen in FL grades 1-3a versus FL grade 3b and DLBCL, the results being the same whether the cases with secondary FL grade 3b/DLBCL were included or not (Table 3 ). In addition, loss from Xp, loss from 14q, and ¡16 were seen more frequently in FL grade 3b/ DLBCL (Table 3) .
FL grades 1, 2, and 3
The karyotypes in all three grades of FL with secondary aberrations were mostly hyperdiploid, 74, 77, and 70% in grades 1, 2, and 3, respectively. Grades 1 and 2 FL showed a median of 5.0 (mean 6.1 and 5.8, respectively) secondary aberrations per case, whereas FL grade 3 showed a median of 7.0 (mean 8.5) aberrations per case. The number of secondary abnormalities showed a tendency to be higher in FL grade 3 than in the combined FL grades 1 and 2 (7.0 and 5.0, respectively, P = 0.070, Mann-Whitney U test), but not in FL grade 1 and 2 combined versus 3a only (5.0 vs. 6.0, respectively, P = 0.373, Mann-Whitney U test, Table 3 ). FL grade 3b was not separately tested due to the low number of cases. Loss of material from the short arm of chromosome 1 was more frequent in grade 3 than in FL grades 1 and 2 (50 vs. 21%, P = 0.011, Fisher's Exact Test). A similar diVerence was seen between FL grades 1 and 2 and FL grade 3a.
Loss from Xp and ¡16 were not seen at all in FL grades 1 and 2, but were found in FL grade 3 (0 vs. 10%, P = 0.031, and 0 vs. 15%, P = 0.005, Fisher's Exact Test, Table 3 ).
Chemotherapy-treated versus untreated patients
No diVerence in the frequency of secondary aberrations was seen between treated and untreated patients. FL patients who had received chemotherapy showed a higher frequency of i (6p) We also compared the total number of secondary cytogenetic aberrations in FL grades 1-3a cases which showed no evidence of histologic transformation during observation time to those FL grades 1-3a cases which showed histologic transformation in a subsequent biopsy. There was no diVerence between these groups (median 5.0 and 6.0, respectively, P = 0.494, Mann-Whitney U test). No speciWc chromosomal aberrations were more frequent in either group.
Survival in the diVerent histologic subgroups Survival was assessed both from diagnosis ( Fig. 1a-c) and from the time of the biopsy with cytogenetic analysis (Figs. 2a, b, 3a-e). As expected, lymphoma cases without histologic evidence of progression had longer overall survival (N = 74, median survival 200 months) than did patients with synchronous or metachronous histologic evidence of progression (N = 50, median survival 73 months, P < 0.001, Log rank test, Fig. 1b ). Patients with a low FLIPI score (Solal-Celigny et al. 2004 ) showed a longer overall survival than did patients with higher FLIPI scores (Fig. 1c) . Survival in the diVerent histologic subgroups is shown in Fig. 2b .
Cytogenetic patterns and survival
The total number of secondary cytogenetic aberrations was signiWcantly associated with disease outcome (Fig. 3a, b) , except for FL grade 3b and DLBCL (Fig. 3c) . When testing the impact of single chromo- Fig. 1 Overall survival from diagnosis. a Overall survival from diagnosis in all 149 patients with t(14;18). b Overall survival in patients with no transformation (n = 74), patients with transformation during observation time (n = 50), and patients with primary follicular lymphoma grade 3b and de novo diVuse large B cell lymphoma (n = 25). c Overall survival in patients with follicular lymphoma by FLIPI score (Follicular Lymphoma International Prognosis Index) (Solal-Celigny et al. 2004) somal aberrations, trisomy 21 had an adverse impact on survival (Fig. 3d , e, P = 0.036 and 0.010, Log rank test), whereas +X was of borderline signiWcance (P = 0.067 for the FL cases, Log rank test). The other chromosomal aberrations were without inXuence on clinical outcome in this analysis.
Multivariate analysis
Cox regression analysis of the FL grade 1-3a cases showed that high FLIPI score (P < 0.001, 95% CI 0.085-0.496), >6 secondary chromosomal aberrations (P = 0.011, 95% CI 1.021-1.160), and +21 (P = 0.001, 95% CI 1.780-11.164) were independently associated with shorter overall survival.
Discussion
Secondary aberrations in NHL with t(14;18) Johansson et al. (1995) and Horsman et al. (2001) reported that 90 and 97% of NHL with t(14;18), or the variant translocations t(2;18) and t(18;22), had secondary chromosomal abnormalities, with as many as up to 34 rearrangements being registered in one of the lymphomas described by Horsman and co-workers (2001) , who restricted their report to FL with t(14;18). This is similar to our Wndings. Only 76 cases of FL and 5 cases of DLBCL with t(14;18) as the sole change are reported in Mitelman's database (2006) showing that the vast majority of NHL with t(14;18) have secondary rearrangements. In our study, the distribution of secondary aberrations was partly nonrandom, with Wve numerical and seven structural abnormalities being seen in more than 10% of the NHL cases with secondary abnormalities (Table 2) .
Secondary aberrations in FL versus DLBCL with t(14;18)
Although we expected to Wnd more aberrations in DLBCL, since this disease is of higher histologic grade and more aggressive than FL in general, we could only demonstrate a weak trend for more aberrations (Table 3 ). The relatively low number of DLBCL cases may be one explanation. Another possible explanation might be that FL grade 3, or at least FL grade 3b, is biologically more similar to DLBCL than to FL grade 1 and 2 (JaVe et al. 2001; Ott et al. 2002) . However, even when FL grade 3b and DLBCL were grouped together and analyzed against FL grade 1-3a (Table 3) , statistical signiWcance was not reached P = 0.092, MannWhitney U test).
Trisomy 7, trisomy 12, and loss from 1q were more frequent in DLBCL than in FL. The most frequent secondary abnormality in DLBCL, trisomy 7, was seen in almost 50% of the DLBCL compared to 20% in FL. From our Wndings it seems likely that trisomy 7 may be an indicator of tumor progression as has already been suggested (Bernell et al. 1998; Boonstra et al. 2003 ). Cigudosa and co-workers (1999) found trisomy 7 more frequently in treated DLBCL patients than in untreated DLBCL patients, but we could not conWrm this since, in our study, trisomy 7 was almost equally frequent in the two groups (43 vs. 57%, respectively). One possible explanation could be the low number of DLBCL cases in our study compared to the 215 DLBCL cases analyzed by Cigudosa and co-workers, or the fact that they looked not only at t(14;18)-positive DLBCL. Another study suggested that secondary abnormalities in t(14;18)-bearing FL follow diVerent pathways (Höglund et al. 2004 ) with +7 suggesting better prognosis. We found no diVerence in overall survival in our patients with regard to +7.
Trisomy 12 was found in 24% of the DLBCL versus 10% in the FL (P = 0.047, Fisher's Exact Test). The diVerence was even more signiWcant when comparing FL grades 1-3a versus FL grade 3b and DLBCL (Table 3) . Trisomy 12 has been reported more frequently in primary diVuse large cell lymphoma than in secondary DLBCL following FL (Younes et al. 1994) . Our data showed the same tendency but the diVerence was not signiWcant. A total of 32% of de novo DLBCL showed trisomy 12, whereas only 13% of DLBCL following FL showed the same trisomy (P = 0.262, Fisher's Exact Test). Gain of 12q has been associated with transformation of FL to DLBCL, with gain of 12q12-q14 being found in over half of the transformed DLBCL examined by Hough et al. (2001) , but never in its follicular counterpart. No such partial gain of 12q was seen in our series.
Loss from 1q, seen in 5% of FL and 22% of DLBCL in our study, has not previously been reported as a frequent aberration secondary to t(14;18). This is in contrast to gain from 1q which has been described in up to 24% of FL (Horsman et al. 2001) .
When comparing FL grades 1-3a with FL grade 3b and DLBCL, three other aberrations were found to be more frequent in FL grade 3b/DLBCL. These were loss from Xp, loss from 14q, and monosomy 16. To our knowledge, these abnormalities have not been previously reported as frequent in t(14;18)-positive NHL. None of them showed an impact on survival in either group.
Secondary aberrations in the three grades of FL
Although there was a higher median number of secondary abnormalities in FL grade 3 than in FL 1 and 2, no statistically signiWcant diVerence was seen (Table 3) . The same result was seen when excluding FL grade 3b. Three abnormalities were statistically more frequent in FL grade 3, namely loss from Xp, loss from 1p, and monosomy 16. Loss from 1p was also signiWcant when excluding FL grade 3b (Table 3) .
Loss from the p-arm of chromosome 1 was found in 26% of the FL in this series. Thirteen of the cases with additional material on chromosome band 1p36, resulting in loss of 1p material, have been described in detail previously (Aamot et al. 2002) , where it was shown that the extra material often came from chromosome arm 17q, especially from chromosome band 17q21. Thirteen percent (4/31) of the FL grade 1 and 17% (10/ 60) of FL grade 2 showed breaks in 1p36, whereas FL grade 3 showed 1p36 breaks in 40% (8/20, 5/15 in FL grade 3a and 3/5 in FL grade 3b). Not only in t(14;18)-carrying NHL but also in other lymphomas, abnormalities of chromosome 1 almost always occur secondarily to more speciWc lymphoma-associated rearrangements and therefore are considered to be part of clonal evolution (Heim and Mitelman 1995) . Association of loss of 1p material with higher grade of FL has been reported (Horsman et al. 2001; Ott et al. 2002) , and deletion of chromosome band 1p36 has also been associated with an unfavorable overall survival (Lestou et al. 2003 ). As stated above, loss from the short arm of the X chromosome or of the whole chromosome 16 has not been frequently reported as secondary abnormalities in t(14;18)-bearing NHL. In our study, they were only seen in FL grade 3.
Clinical importance of chromosomal aberrations
The patients included in the study have been treated according to generally accepted international guidelines (see Materials and methods, Patients and treatment). No diVerence in overall survival in low-grade NHL has been found in clinical studies comparing watch and wait with chemotherapy until clinical symptoms (Solal-Celigny 2002) or chlorambucil monotherapy with CHOP based chemotherapy as Wrst line chemotherapy (Kimby et al. 1994) . Although one might expect chemotherapy to inXuence clonal selection, we did not Wnd any diVerence between the treated and untreated patients when looking at the number of chromosome abnormalities/breaks and only i(6p) and loss from 6q showed a signiWcantly higher frequency in treated FL patients than in untreated FL patients, also when excluding FL grade 3b. No diVerence in overall survival was seen for the FL grade 1-3a patients with and without loss from 6q also when dividing them according to chemotherapy status. The cause of the higher frequency of i(6p) and loss from 6q in treated FL patients could possibly be the treatment given or that the biopsies were taken at a later stage.
Number of chromosomal aberrations
Patients with a low number of chromosomal aberrations had a longer survival compared to those with a high number (lower vs. higher than the median number), both for all patients and for those with FL grades 1-3a. Others have reported similar correlations (Tilly et al. 1994 ). This was not found in FL grade 3b/ DLBCL, however. The low number of cases in the FL grade 3b/DLBCL group might be the explanation for the lack of statistical signiWcance. The lower number of these cases was expected since t(14;18) is seen in only 13-17% of DLBCL cases (Barrans et al. 2003; Iqbal et al. 2004 ) compared to 80-90% in FL (Horsman et al. 1995) . Another possible explanation might be that clonal evolution occurred faster in these cases than in FL grades 1-3a (Table 1) . We were also unable to show a diVerence in the number of chromosomal aberrations between transformed and primary DLBCL cases. The t(14;18) translocation may in itself impose a negative impact on survival in DLBCL as found in one study (Barrans et al. 2003) but not in another (Iqbal et al. 2004 ). The translocation is conWned to the germinalcenter type of DLBCL Barrans et al. 2003) . Furthermore, t(14;18) is not as frequent in the FL grade 3b subset of lymphomas as in the other histologic grades of FL Bosga-Bouwer et al. 2003) , but the clinical signiWcance of this histologic group of FL is not yet fully understood.
SpeciWc chromosomal aberrations
A new Wnding of this study was the shorter survival for patients with +21, both in univariate and multivariate analysis (for the FL cases). Trisomy 21 has been reported previously as frequent in t(14;18)-positive NHL (Yunis et al. 1987; Mohamed et al. 2001; Lestou et al. 2003) , but correlation with clinical parameters was either not performed or found. Another study, however, found association between trisomy 21 and poor survival in follicular large cell lymphomas with and without t(14;18) (Weisenburger et al. 2000) . We showed earlier that +21 was associated with marginal zone diVerentiation in FL (Torlakovic et al. 2006) . Marginal zone diVerentiation has been suggested to be an unfavorable Wnding in FL (Nathwani et al. 1999; Goodlad et al. 2003) , but larger studies with survival analysis are needed to conWrm this contention. Interestingly, we found that +X should also be considered as a potentially adverse Wnding in FL (P = 0.069). Loss from 14q, monosomy 15, trisomy 16, and trisomy 22 were signiWcantly more frequent in patients with synchronous evidence of histologic progression compared to patients with FL grades 1-3a, but because the former patients were few (N = 17), the value of these Wndings is uncertain and needs to be conWrmed in future studies.
Lack of prediction of transformation to DLBCL Tilly and co-workers (1994) found that deletions of the long arm of chromosome 6 and of the short arm of chromosome 17 predict histologic transformation. In this study, we were unable to show any speciWc chromosomal aberrations that could identify cases among the 107 FL that would later transform to FL grade 3b/ DLBCL (33 cases). The explanation for this discrepancy is not clear. In this respect, molecular analyses may be more useful since there is a number of known molecular events that have been shown to be associated with histologic progression, including mutations of TP53 (Davies et al. 2005), p16 INK4a (Pinyol et al. 1998) , BCL6 (Lossos and Levy 2000) , and deregulation of MYC expression (Lossos et al. 2002) .
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